SEC Form 4 · accession 0001225208-18-005503
Cigna Holding Co · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Cordani
Officer — President & CEO · Director
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.25 Par ValueF1 | Mar 2, 2018 | A | 67,070 | $0.00 | A | 372,076 | D | |
| Common Stock, $.25 Par ValueF2 | Mar 2, 2018 | F | 30,301 | $192.44 | D | 341,775 | D | |
| Common Stock, $.25 Par ValueF4 | Mar 5, 2018 | S | 2,500 | $192.7341 | D | 339,275 | D | |
| Common Stock, $.25 Par ValueF5 | Mar 5, 2018 | S | 5,000 | $190.2443 | D | 334,275 | D | |
| Common Stock, $.25 Par ValueF6 | Mar 5, 2018 | S | 10,899 | $191.3551 | D | 323,376 | D | |
| Common Stock, $.25 Par ValueF7 | Mar 5, 2018 | S | 18,370 | $192.1155 | D | 305,006 | D | |
| Common Stock, $.25 Par ValueF8 | holding | — | — | — | 1,640 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2015-2017 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- F2Represents shares withheld to satisfy tax obligations upon vesting.
- F3This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
- F4Represents the weighted average price of the shares sold. The prices actually received ranged from $192.64 to $192.90 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F5Represents the weighted average price of the shares sold. The prices actually received ranged from $189.64 to $190.61 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F6Represents the weighted average price of the shares sold. The prices actually received ranged from $190.65 to $191.64 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F7Represents the weighted average price of the shares sold. The prices actually received ranged from $191.642 to $192.63 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F8Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.